HLX-99

N/A

Report date: 2025/10/29 17:44:31
NME

Base Information

Drug NameHLX-99
Drug Alias NameHLX99HLX-99
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesShanghai Henlius Biopharmaceuticals Co LtdShanghai Henlius Biotech Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Henlius Biotech IncShanghai Henlius Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A